Esters of 2-phenylalkanenitriles and antifungal compositions containing them
申请人:Stoutamire Donald Wesley
公开号:US20080153905A1
公开(公告)日:2008-06-26
Esters of 2-phenylalkanenitriles, such as 3-acetoxy-2-(2-chloro-5-(difluoromethoxy)phenyl)propanenitrile and 3-acetoxy-2-(4-chlorophenyl)propanenitrile, and compositions containing such esters, are useful as fungicides at very low concentrations.
A magnetic nanoparticle catalyzed eco-friendly synthesis of cyanohydrins in a deep eutectic solvent
作者:Najmedin Azizi、Zahra Rahimi、Masoumeh Alipour
DOI:10.1039/c5ra06176h
日期:——
Magnetic Fe3O4 nanoparticles in deep eutectic solvents (DESs) have been regard as excellent catalysts for highly efficient cyanosilylation of various aldehydes and epoxides using trimethylsilyl cyanide TMSCN in high yields with excellent selectivity. Fe3O4 nanoparticles were synthesized and applied as a catalyst for the preparation of a wide variety of cyanohydrins (α-hydroxy nitriles and β-hydroxy
在低共熔溶剂(DES)中的磁性Fe 3 O 4纳米粒子已被视为出色的催化剂,可使用三甲基甲硅烷基氰化物TMSCN高产率,高选择性地对各种醛和环氧化物进行高效氰基硅烷化。合成了Fe 3 O 4纳米颗粒,并将其用作催化剂,用于在容易获得的尿素-氯化胆碱深度低共熔溶剂DES中制备各种氰醇(α-羟基腈和β-羟基腈),这是最有希望的对环境有益的,具有成本效益的绿色溶剂。磁性DES在非常温和的反应条件下运行,可以很容易地回收利用,而不会显着降低其催化活性。
ESTERS OF 2-PHENYLALKANENITRILES AND ANTIFUNGAL COMPOSITIONS CONTAINING THEM
申请人:Stoutamire Donald Wesley
公开号:US20100022640A1
公开(公告)日:2010-01-28
Esters of 2-phenylalkanenitriles, such as 3-acetoxy-2-(2-chloro-5-(difluoromethoxy)phenyl)propanenitrile and 3-acetoxy-2-(4-chlorophenyl)propanenitrile, and compositions containing such esters, are useful as fungicides at very low concentrations.
DIHYDROTHIENO PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
申请人:Mitchell Ian S.
公开号:US20120329808A1
公开(公告)日:2012-12-27
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula:
Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula:
Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.